Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 1, 2013Current Topics in Medicinal Chemistry

Discovering New Treatments for Alzheimer's Disease by Repurposing Approved Medications

View Full Paper
Ask AI
Bookmark
Share

Authors

BABrian S. ApplebyUniversity Hospitals of Cleveland
Jeffrey L. Cummings
Jeffrey L. CummingsCleveland Clinic

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Appleby et al. (2013) studied this question.

synapsesocial.com/papers/6a10fe5049545a83bbeecf86https://doi.org/10.2174/15680266113136660162
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Restoration of dietary-fat induced blood–brain barrier dysfunction by anti-inflammatory lipid-modulating agents2012 · 57 citations
  2. 2Cochrane review on ‘Statins for the treatment of dementia’2012 · 64 citations
  3. 3β-Amyloid-Mediated Inhibition of NMDA Receptor-Dependent Long-Term Potentiation Induction Involves Activation of Microglia and Stimulation of Inducible Nitric Oxide Synthase and Superoxide2004 · 192 citations
  4. 4RNA Therapeutics Directed to the Non Coding Regions of APP mRNA, In Vivo Anti-Amyloid Efficacy of Paroxetine, Erythromycin, and N-acetyl cysteine2006 · 61 citations
  5. 5Antidiabetic drug metformin (Glucophage R ) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription2009 · 387 citations